. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angiogenesis Inhibitors/adverse effectsAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedBevacizumabBrain Neoplasms/drug therapyBrain Neoplasms/radiotherapyBrain Neoplasms/surgeryChemotherapy, AdjuvantCombined Modality TherapyCraniotomyDebridementDura Mater/surgeryGlioblastoma/drug therapyGlioblastoma/radiotherapyGlioblastoma/surgeryHumansMaleMicrosurgeryMiddle AgedNeoplasm Recurrence, Local/drug therapyNeoplasm Recurrence, Local/radiotherapyNeoplasm Recurrence, Local/surgeryPostoperative Complications/etiologyPostoperative Complications/surgeryRadiotherapy, AdjuvantReoperationRisk FactorsScalp/drug effectsScalp/radiation effectsScalp/surgerySkin TransplantationSurgical Flaps/blood supplySurgical Wound Dehiscence/etiologySurgical Wound Dehiscence/surgeryWound Healing/physiology
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBevacizumab
Year: 2008 PMID: 18626384 DOI: 10.1097/PRS.0b013e31817d7f91
Source DB: PubMed Journal: Plast Reconstr Surg ISSN: 0032-1052 Impact factor: 4.730